WALLENTIN, L., BECKER, R.C., BUDAJ, A., CANNON, C.P., ET AL (WILCOX, R.G and MEMBER OF THE DSMB), 2009. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndrome: PLATO The New England Journal of Medicine. 361(11), 1045-1057
MEGA, J.L, BRAUNWALD, E, MOHANAVELU, S and ET AL (WILCOX, R.G. STEERING COMMITTEE AND UK LEAD INVESTIGATOR), 2009. Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial. The Lancet. 374, 29-38
CARVER, A, RAFELT, S, GERSHLICK, A.H, FAIRBROTHER, K.L, HUGHES, S and WILCOX, R.G. FOR THE REACT INVESTIGATORS., 2009. Longer-Term Follow-Up of Patients Recruited to the REACT (Rescue Angioplasty Versus Conservative Treatment or Repeat Thrombolysis) Trial Journal of the American College of Cardiology. 54(2),
AKERBLOM, J.S, CANNON, C, EMANUELSSON, G, ET AL (WILCOX, R.G and MEMBER OF THE DSMB), 2009. Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndrome: Rationale, design and baseline characteristics of the PLATelet inhibition and patient Outcome trial.: PLATO American Heart Journal. 157, 599-605
ERDMANN, E and AND WILCOX, R.G., 2008. Weighing up the cardiovascular benefits of thiazolidinedione therapy: the impact of increased risk of heart failure European Heart Journal. 29(1), 12-20
ALP, N.J, GERSHLICK, A.H, CARVER, A, STEVENS, S.E and WILCOX, R.G., 2008. Rescue angioplasty for failed thrombolysis in older patients: Insights from the REACT trial. International Journal of Cardiology. 125(2), 254-257
WILCOX, R.G, KUPFER, S, AND ERDMANN, E and ON BEHALF OF THE PROACTIVE STUDY INVESTIGATORS., 2008. Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: Results from PROspective pioglitAzone Clinical Trial in macro Vascular Events (PROactive 10) American Heart Journal. 155(1), (In Press.)
TANGELDER, M, FRISON, L, WEAVER, D, WILCOX, R, BYLOCK, A, EMANUELSSON, H, HELD, P and AND OLDGREN, J., 2008. American Heart Journal. 155(2), 382-387
WIVIOTT, S.D, BRAUNWALD, E, MCCABE, C.H and ET AL. (WILCOX, R.G. UK PRINCIPAL INVESTIGATOR AND STEERING COMMITTEE MEMBER)., 2007. Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes The New England Journal of Medicine. 357(20), 2001-15 (In Press.)
STOREY, R., HARRINGTON, R, A., HUSTED, S., HEPTINSTALL, S., WILCOX, R., GURBEL, A., GRANDE, P., WICKENS, M., PETERS, G., EMANUELSSON, H. and CANNON, C., 2007. AZD6140 Suppresses Platelet Aggregation in Clopidogrel-Treated Patients Even in Those With High Aggregation Levels JACC. 49(9 (Supplement A)),
XAVIER, R, WHITE, A, FOX, S, WILCOX, R and AND HEPTINSTALL, S., 2007. Enhanced platelet aggregation and activation under conditions of hypothermia Thrombosis and Haemostasis. 98(6), 1266-1275
WILCOX, R., BOUSSER, M-G., PIRAG, V., BETTERIDGE, J., SCHERNTHANER, G., KUPFER, S. and DORMANDY, J., 2007. Stroke. 38(3), 865-873
ERDMANN, E, DORMANDY, J, WILCOX, R, MASSI-BENEDETTI, M and AND CHARBONNEL, B., 2007. PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactuve study Vascular Health and Risk Management. 3(4), 355-370
ERDMANN, E., WILCOX, R., PEREZ, A., YATES, J., SPANHEIMER, R. and DORMANDY, J., 2007. Mortality after Serious Heart Failure: Results from PROactive JACC. 49(9), 66A
STOREY, R.F, HUSTED, S, HARRINGTON, R.A, HEPTINSTALL, S, WILCOX, R.G, PETERS, G, WICKENS, M, EMANUELSSON, H, GURBEL, P, GRANDE, P and AND CANNON, C.P., 2007. Inhibition of Platelet Aggregation by AZD6140, A Reversible Oral P2Y12 Receptor Antagonist, Compared with Clopidogrel in Patients with Acute Coronary Syndromes. Journal of the American College of Cardiology. 50(19), 1852-1856 (In Press.)
HEPTINSTALL, S., FOX, S., GLENN, J., JOHNSON, A., WHITE, A., HATZINOCOLAU, M., PINK, A., STAFFORD, N., BEHAN, M., DOLAN, G. and MYERS, B., 2006. Effects of blood leucocytes on platelet aggregation - a review of recent studies on leucocytes, adenine nucleotide metabolism and CD39 Seminars in Cardiology. 12(2), 43-54 RAO, ARCHANA, ASADI-LARI, MOHSEN, WALSH, JOHN, WILCOX, ROBERT and GRAY, DAVID, 2006. Journal of cardiac failure. 12(9), 677-83
WILCOX, R., 2006. An Analysis from PROactive on the effects of pioglitazone on major adverse cardiovascular events (MACE) and myocardial infarction. Diabetologia. 49 (Supplement 1)(72),
WILCOX, R., 2006. An analysis from PROactive on the Effects of Pioglitazone on Myocardial Infarction and Major Adverse Cardiovascular Events (MACE) in Patients with Type 2 Diabetes (Abstract). European Heart Journal. 27(supplement)(535),
STOREY R.F., HARRINGTON R.A., HUSTED S., HEPTINSTALLS., WILCOX R.G. and ET AL, 2006. AZD6140 Yields additional suppression of platelet aggregation in patients with acute coronary syndrome previously treated with clopidogrel. In: 204 (A821-4)
WILCOX, R.G., BOUSSER, M-G. and DORMANDY, J. ON BEHALF OF THE PROACTIVE INVESTIGATORS., 2006. The effects of pioglitazone in patients with or without a history of stroke (> 6 months prior to randomisation) - a pre-specified subgroup analysis of PROactive. In: World Congress of Cardiology. A204 (no 821-4).
STOREY R.F., HUSTED S, HARRINGTON R.A., HEPTINSTALL S., WILCOX R.G. and ET AL., 2006. AZD6140 Yields greater inhibition of platelet aggregation than clopidogrel in patients with acute coronary syndromes without previous clopidogrel treatment. In: 204 (A821)
HOUGHTON A. and GRAY D., 2006. In: HODDER, ed., Making Sense of the ECG. A hands-on guide.: International Student's Edition 2nd ed. Edward Arnold. 278
BODY, S., ASGARI, K., RICKARD, J. F., ZHANG, Z., FONE, K. C., BRADSHAW, C. M. and SZABADI, E., 2005. Psychopharmacology. VOL 181(NUMBER 2), 289-298
PITT B, WHITE H, NICOLAU J, ET AL (WILCOX, R.G. STEERING COMMITTEE MEMBER AND UK LEAD INVESTIGATOR)., 2005. American College of Cardiology. Journal. 46, 425
WILCOX, R.G., AMBROSIONI R., PATNI R., MUKERHERJEE R. and PITT B., 2005. Effect of eplerenone in patients with normal renal function and mild renal insufficiency: results from the EPHESUS trial. In: European Society of Cardiology.. PO P1772
GERSHLICK, A.H., STEPHENS-LLOYD, A. and WILCOX, R.G., 2005. Rescue angioplasty v conservative treatment or repeat thrombolysis for failed thrombolysis in acute MI: the REACT trial one year clinical outcome. In: European Society of Cardiology, Stockholm, Sept 2005. 562
WILCOX,R.G., 2005. General principles of fibrinolytic therapy in acute myocardial infarction.. In: Coronary Reperfusion Therapy in Clinical Practice. Taylor & Francis Ltd, London. 43-64
SABATINE, M.S., CANNON C.P., GIBSON, C.M., L脫PEZ-SEND脫N, J.L., MONTALESCOT, G., THEROUX, P., CLAEYS, M.J., COOLS, F., HILL, K.A., SKENE, A.M., MCCABE, C.H. and BRAUNWALD, E., 2005. New England Journal of Medicine. 352(12), 1179-1189
DORMANDY, J.A., CHARBONNEL, B., ECKLAND, D.J.A., ERDMANN, E., MASSI-BENEDETTI, M., MOULES, I.K., SKENE, A.M., TAN, M.H., LEF脠BVRE, P.J., MURRAY, G.D., STANDL, E., WILCOX, R.G., WILHELMSEN, L., BETTERIDGE, J., BIRKELAND, K., GOLAY, A., HEINE, R.J., KOR脕NYI, L., LAAKSO, M., MOK脕艊, M., NORKUS, A., PIRAGS, V., PODAR, T., SCHEEN, A., SCHERBAUM, W., SCHERNTHANER, G., SCHMITZ, O., 艩KRHA, J., SMITH, U., TATO艊, J. and ON BEHALF OF THE PROACTIVE INVESTIGATORS, 2005. Lancet. 366(9493), 1279-1289
GERSHLICK, A.H., STEPHENS-LLOYD, A., HUGHES, S., ABRAMS, K.R., STEVENS, S.E., UREN, N.G., DE BELDER, A., DAVIS, J., PITT, M., BANNING, A., BAUMBACH, A., SHIU, M.F., SCHOFIELD, P., DAWKINS, K.D., HENDERSON, R.A., OLDROYD, K. and WILCOX, R.G., 2005. New England Journal of Medicine. 353(26), 2758-2768
NALLAMOTHU, BRAHMAJEE K, BATES, ERIC R, HOCHMAN, JUDITH S, GRANGER, CHRISTOPHER B, GUETTA, VICTOR, WILCOX, ROBERT G, WHITE, HARVEY D, ARMSTRONG, PAUL W, SAVONITTO, STEFANO, JIA, GANG and LINCOFF, A MICHA, 2005. European Heart Journal. 26(15), 1506-12
GURM, H. S., SAREMBOCK, I. J., KEREIAKES, J., YOUNG, J. J., HARRINGTON, R. A., KLEIMAN, N., FEIT, F., WOLSKI, K., BITTL, J. A. and WILCOX, R., 2005. American College of Cardiology. Journal. VOL 45(NUMB 12), 1932-1938
GERSHLICK, A.H., UREN, N., DE BELDER, A. and WILCOX, R.G., 2005. The REACT (Rescue Angioplasty v. Conservative Treatment or Repeat Thrombolysis) Trial: Results according to actual treatment received. In: British Cardiac Society, Annual Scientific Conference, 23-26 May 2005. A22, No A063
TOFF, W.D., CAMM, A.J., SKEHAN, D. and (WILCOX, R.G. INVESTIGATOR), 2005. New England Journal of Medicine. 353(2), 145-155
GERSHLICK, A.H., HUGHES, S. and WILCOX, R.G., 2005. The REACT (Rescue Angioplasty v. Conservative Treatment or Repeat Thrombolysis) Trial: Impact of age upon efficacy of treatment. In: British Cardiac Society proceedings. A24
BRENER, S. J., LINCOFF, A. M., BATES, E. R., JIA, G., ARMSTRONG, P. W., GUETTA, V., HOCHMAN, J. S., SAVONITTO, S., WILCOX, R. G. and WHITE, H. D., 2005. American Heart Journal. VOL 150(NUMBER 1), 89-93
GERSHLICK, A.H., HUGHES, S.L., STEPHENS-LLOYD, A. and WILCOX, R.G., 2005. Rescue angioplasty v conservative treatment or repeat thrombolysis for failed lysis: 6 months outcome according to treatment actually received In: European Society of Cardiology, Stockholm September 2005. P3426, p562
WILCOX, R.G., 2004. Combination of the oral direct thrombin inhibitor Ximelagatran with acetyl salicylic acid (ASA) after acute myocardial infarction (MI): 1 year outcome following the start of 6 months treatment. Heart. 90(Suppl 2), 153
MENON, V., HARRINGTON, R. A., HOCHMAN, J. S., CANNON, C. P., GOODMAN, S. D., WILCOX, R. G., SCHUNEMANN, H. J. and OHMAN, E. M., 2004. Chest. VOL 126(NUMB 3), 549S-575S
PATRONO, C. and WILCOX, R.G., 2004. European Society of Cardiology. Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European Society of Cardiology. European Heart Journal. 25(2), 166-181
FOX, K. A. A., BIRKHEAD, J., WILCOX, R., KNIGHT, C. and BARTH, J., 2004. Heart. VOL 90(PART 6), 603-609
GURM, HITINDER S, LINCOFF, A MICHAEL, LEE, DAVID, TANG, W H WILSON, JIA, GANG, BOOTH, JOAN E, CALIFF, ROBERT M, OHMAN, E M, VAN DE WERF, FRANS, ARMSTRONG, PAUL W, GUETTA, VICTOR, WILCOX, ROBERT, TOPOL, ERIC J and ,, 2004. American College of Cardiology. Journal. 43(4), 542-8
LINCOFF, A MICHAEL, KLEIMAN, NEAL S, KEREIAKES, DEAN J, FEIT, FREDERICK, BITTL, JOHN A, JACKMAN, J DANIEL, SAREMBOCK, IAN J, COHEN, DAVID J, SPRIGGS, DOUGLAS, EBRAHIMI, RAMIN, KEREN, GADI, CARR, JEFFREY, COHEN, ERIC A, BETRIU, AMADEO, DESMET, WALTER, RUTSCH, WOLFGANG, WILCOX, ROBERT G, DE FEYTER, PIM J, VAHANIAN, ALEC, TOPOL, ERIC J and ,, 2004. Journal of the American Medical Association. 292(6), 696-703
CHARBONNEL, B., DORMANDY, J., ERDMANN, E., MASSI-BENEDETTI, M., SKENE, A.M. and WILCOX, R.G., 2004. Diabetes Care. 27(7), 1647-1653
SAW, J., LINCOFF, A. M., DESMET, W., BETRIU, A., RUTSCH, W., WILCOX, R. G., KLEIMAN, N. S., WOLSKI, K., TOPOL, E. J. and REPLACE-2 INVESTIGATORS, 2004. American College of Cardiology. Journal. VOL 44(NUMB 6), 1194-1199
DESMET, W., SAW, J., LINCOFF, A. M., BETRIU, A., RUTSCH, W., WILCOX, R. G., KLEIMAN, N. S., TOPOL, E. J. and REPLACE-2, I., 2003. European Heart Journal. VOL 24(NUMBER 5), 548
WILCOX, R.G., 2003. General Principles of Fibrinolytic Therapy in Acute MI. In: Fibrinolytic Therapy in Clinical Practice
MCKENZIE, DANIEL B and WILCOX, ROBERT G, 2003. Expert Opinion on Pharmacotherapy. 4(1), 41-54
MCKENZIE, D.B. and WILCOX, R.G., 2003. Metformin and Chronic Heart Failure. Lancet. 362, 919.
HO, M.-Y., BODY, S., KHERAMIN, S., BRADSHAW, C. M. and SZABADI, E., 2003. Psychopharmacology. VOL 167(PART 2), 137-144
PITT B., REMME W., ZANNAD F., ET AL and (WILCOX, R.G. STEERING COMMITTEE MEMBER AND UK PRINCIPAL INVESTIGATOR)., 2003. New England Journal of Medicine. 348(14), 1309-1321
WALLENTIN, L., WILCOX, R.G., WEAVER, W.D., EMANUELSSON, H., GOODVIN, A., NYSTR脰M, P. and BYLOCK, A., 2003. Lancet. 362(9386), 789-797
ANDERSON, I. M., RICHELL, R. A. and BRADSHAW, C. M., 2003. Journal of Psychopharmacology. VOL 17(PART 1), 3-8
SAW, J., DESMET, W., LINCOFF, A.M., BETRIU, A., RUTCH, W., WILCOX, R.G., KLEIMAN, N.S. and TOPOL, E.J., 2003. Clopidogrel Pretreatment Does not Influence the Relative Efficacy of Bivalirudin with Provisional GPIIb/IIIa Blockade vs Heparin with Routine GPIIb/IIIa Blockade. A REPLACE-2 Substudy. Circulation (Baltimore). 108(17), Abs: 2597
WONG, C. K., WHITE, H. D., WILCOX, R. G., CRIGER, D. A., CALIFF, R. M., TOPOL, E. J. and OHMAN, E. M., 2003. Cardiac Electrophysiology Review. VOL 7(NUMBER 3), 201-207
BRADSHAW,C.M., 2003. Neuropharmacology. In: HALLIGAN,P.W., KISCHKA, U. and MARSHALL, J.C, eds., Handbook of Clinical Neuropsychology Oxford University Press. 445-469
LINCOFF, A.M., WILCOX, R.G., BITTL, J.A. and HARRINGTON, R.A., 2003. Journal of the American Medical Association. 289(7), 853-63
CHO, LESLIE, BHATT, DEEPAK L, BRENNAN, DANIELLE, WILCOX, ROBERT G and TOPOL, ERIC J, 2003. American Journal of Cardiology. 91(6), 721-3
WALLENTIN, L.C., WILCOX, R.G., WEAVER, D., EMANUELSSON, H., GOODVIN, A., NYSTROM, P. and BYLOCK, A., 2003. Combination of the Oral Direct Thrombin Inhibitor Ximelagatran with Acetyl Salicylic Acid (ASA) after Acute myocardial infarction: 1-year Outcome. Clinical Science. IV-501Abs2284
MCKENZIE, DANIEL B and WILCOX, ROBERT G, 2003. Heart failure: treatment and ethnic origin. Lancet. 362(9387), 919
WONG, C.-K., WHITE, H. D., WILCOX, R. G., CRIGER, D. A., CALIFF, R. M., TOPOL, E. J., OHMAN, E. M. and GUSTO-III INVESTIGATORS, 2002. Heart. VOL 88(PART 4), 357-362
O`SHEA, J. C., WILCOX, R. G., SKENE, A. M., STEBBINS, A. L., GRANGER, C. B., ARMSTRONG, P. W., BODE, C., ARDISSINO, D., EMANUELSSON, H. and AYLWARD, P. E., 2002. American Journal of Cardiology. VOL 90(NUMBER 12), 1374-1377
LARGE, G.A., GRAY, D., WILCOX, R.G. and HAMPTON, J.R., 2002. Early revascularisation for non-ST-segment elevation acute coronary syndromes: an estimation of demand in the UK. European Heart Journal. 23((suppl S)), 585
HO, M-Y, VEL脙隆ZQUEZ-MART脙颅NEZ, D N, BRADSHAW, C M and SZABADI, E, 2002. Pharmacology, Biochemistry and Behavior. 71(4), 773-85
SZABADI, E., LANGLEY, R.W. and BRADSHAW, C.M., 2002. Comparison of single doses of noradrenergic drugs on pupillary fatigue waves in a patient with excessive daytime sleepiness Journal of Sleep Research. 11(JSR 11 (Suppl. 1)), 260
GRAHAM, S J, LANGLEY, R W, BALBOA, VERDUZCO A M, BRADSHAW, C M and SZABADI, E, 2002. Effects of ketanserin and haloperidol on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man. Journal of Psychopharmacology. 16(1), 15-22
MOBINI, S, BODY, S, HO, M-Y, BRADSHAW, C M, SZABADI, E, DEAKIN, J F W and ANDERSON, I M, 2002. Psychopharmacology. 160(3), 290-8
BODY, S., KHERAMIN, S., MOBINI, S., HO, M.-Y., VELAZQUEZ-MARTINEZ, D. N., BRADSHAW, C. M. and SZABADI, E., 2002. Behavioural Pharmacology. VOL 13(PART 8), 603-614
BODY, S., CHIANG, T. J., MOBINI, S., HO, M. Y., BRADSHAW, C. M. and SZABADI, E., 2002. Pharmacology, Biochemistry and Behavior. VOL 71(NUMBER 4), 787-793
BOERSMA, ERIC, HARRINGTON, ROBERT A, MOLITERNO, DAVID J, WHITE, HARVEY, TH脡ROUX, PIERRE, VAN DE WERF, FRANS, DE TORBAL, ANNEKE, ARMSTRONG, PAUL W, WALLENTIN, LARS C, WILCOX, ROBERT G, SIMES, JOHN, CALIFF, ROBERT M, TOPOL, ERIC J and SIMOONS, MAARTEN L, 2002. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet. 359(9302), 189-98 KHERAMIN, S., BODY, S., MOBINI, S., HO, M.Y., VELAZQUEZ-MARTINEZ, D.N., BRADSHAW, C.M., SZABADI, E., DEAKIN, J.F. and ANDERSON, I.M., 2002. Psychopharmacology. 165(1), 9-17
BITSIOS, P., SZABADI, E. and BRADSHAW, C. M., 2002. International Journal of Psychophysiology. VOL 43(NUMBER 2), 177-184
BROOKS, J. and WILCOX, R.G., 2001. Guidelines for the management of patients with acute coronary syndromes without persistent ECG ST segment elevation.
GIUGLIANO, R. P., MCCABE, C. H., ANTMAN, E. M., CANNON, C. P., VAN DE WERF, F., WILCOX, R. G., BRAUNWALD, E. and THROMBOLYSIS IN MYOCARDIAL INFARCTION (TIMI) INVESTIGATORS BOSTON, 2001. American Heart Journal. VOL 141(PART 5), 742-750
GREENBAUM, A B, HARRINGTON, R A, HUDSON, M P, MACAULAY, C M, WILCOX, R G, SIMOONS, M L, BERDAN, L G, GUERCI, A, COKKINOS, D V, KITT, M M, LINCOFF, A M, TOPOL, E J, CALIFF, R M and OHMAN, E M, 2001. American College of Cardiology. Journal. 37(2), 492-8
ABDULJAWAD, K A, LANGLEY, R W, BRADSHAW, C M and SZABADI, E, 2001. Effects of clonidine and diazepam on prepulse inhibition of the acoustic startle response and the N1/P2 auditory evoked potential in man. Journal of Psychopharmacology. 15(4), 237-42
PRETORIUS, J L, PHILLIPS, M, LANGLEY, R W, SZABADI, E and BRADSHAW, C M, 2001. British Journal of Clinical Pharmacology. 52(3), 322-6
GRAHAM, S. J., LANGLEY, R. W., BRADSHAW, C. M. and SZABADI, E., 2001. Effects of haloperidol and clozapine on prepulse inhibition of the acoustic startle response and the N1/P2 auditory evoked potential in man Journal of Psychopharmacology. VOL 15(PART 4), 243-250
BODY, S., CHIANG, T.-J., MOBINI, S., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 2001. Psychopharmacology. VOL 158(PART 3), 305-313
STOREY, R F, OLDROYD, K G and WILCOX, R G, 2001. Open multicentre study of the P2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndromes. Thrombosis and Haemostasis. 85(3), 401-7
WILCOX, R.G., 2001. Lancet. 358, 1855-1863
WILCOX, R G, 2001. European Heart Journal. 22(9), 722-4
WILCOX, R.G., 2001. Lancet. 357(June), 1905-1914
LLEVADOT, D., GIUGLIANO, R., ANTMAN, E., WILCOX, R.G., GURFINKEL, E., HENRY, T., MCCABE, C.H., CHARLESWORTH, A., THOMPSON, S., NICOLAU, J., SADOWSKI, Z. and BRAUNWALD, E., 2001. European Heart Journal. 22(22), 2104-2115
WILCOX, R.G., 2001. Lancet. 357(June), 1915-1924
CANNON, C P, MCCABE, C H, WILCOX, R G, BENTLEY, J H and BRAUNWALD, E, 2001. American Journal of Cardiology. 87(5), 636-9, A10
GIUGLIANO, R P, LLEVADOT, J, WILCOX, R G, GURFINKEL, E P, MCCABE, C H, CHARLESWORTH, A, THOMPSON, S L, ANTMAN, E M, BRAUNWALD, E and ,, 2001. European Heart Journal. 22(18), 1702-15
ARONOW, H D, TOPOL, E J, ROE, M T, HOUGHTALING, P L, WOLSKI, K E, LINCOFF, A M, HARRINGTON, R A, CALIFF, R M, OHMAN, E M, KLEIMAN, N S, KELTAI, M, WILCOX, R G, VAHANIAN, A, ARMSTRONG, P W and LAUER, M S, 2001. Lancet. 357(9262), 1063-8
AKKERHUIS, K M, DECKERS, J W, BOERSMA, E, HARRINGTON, R A, STEPINSKA, J, MAHAFFEY, K W, WILCOX, R G, LINCOFF, A M, KELTAI, M, TOPOL, E J, CALIFF, R M and SIMOONS, M L, 2000. European Heart Journal. 21(5), 371-81
DAVIS, C., HO, M., BRADSHAW, C.M. and SZABADI, E., 2000. Estimation of premorbid performance on Raven's Standard Progressive Matrices using reading-test performance: New normative data Clinical Neuropsychological Assessment. 2, 113-123
PHILLIPS, M A, BITSIOS, P, SZABADI, E and BRADSHAW, C M, 2000. Psychopharmacology. 149(1), 72-6
CHIANG, T.-J., AL-RUWAITEA, A. S., MOBINI, S., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 2000. Psychopharmacology. VOL 150(PART 2), 170-184
SZABADI, E. and BRADSHAW, C. M., 2000. Mechanisms of action of reboxetine Reviews in contemporary pharmacotherapy. VOL 11(PART 5), 267-282
PHILLIPS, M. A., SZABADI, E. and BRADSHAW, C. M., 2000. British Journal of Clinical Pharmacology. VOL 50(PART 1), 65-68
TAVERNOR, S J, ABDULJAWAD, K A, LANGLEY, R W, BRADSHAW, C M and SZABADI, E, 2000. Effects of pentagastrin and the cold pressor test on the acoustic startle response and pupillary function in man. Journal of Psychopharmacology. 14(4), 387-94
PHILLIPS, M. A., LANGLEY, R. W., BRADSHAW, C. M. and SZABADI, E., 2000. The effects of some antidepressant durgs on prepulse inhibition of the acoustic startle (eyeblink) response and the NI/P2 auditory evoked response in man Journal of Psychopharmacology. VOL 14(PART 1), 40-45
DAVIS, C., LANGLEY, R.W., HO, M., BRADSHAW, C.M. and SZABADI, E., 2000. Normative data on a computerized graded conditional discrimination (choice reaction time) task Clinical Neuropsychological Assessment. 3, 217-230
BANJAR, W. M. A., GAZZAZ, J., LANGLEY, R. W., BRADSHAW, C. M. and SZABADI, E., 2000. British Journal of Clinical Pharmacology. VOL 50(PART 4), 360-365
PHILLIPS, M A, OXTOBY, E K, LANGLEY, R W, BRADSHAW, C M and SZABADI, E, 2000. Effects of acute tryptophan depletion on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man. Journal of Psychopharmacology. 14(3), 258-65
CANNON, C P, MCCABE, C H, WILCOX, R G, LANGER, A, CASPI, A, BERINK, P, LOPEZ-SENDON, J, TOMAN, J, CHARLESWORTH, A, ANDERS, R J, ALEXANDER, J C, SKENE, A and BRAUNWALD, E, 2000. Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial. Circulation (New York, N.Y.). 102(2), 149-56
BERTRAND, M.E., RUPPRECHT, H.J., GERSHLICK, A.H. and WILCOX, R.G., 2000. Double-blind Study of the Safety of Clopidogrel With and Without a Loading Dose in Combination with Aspirin Compared with Ticlopidine in Combination with Aspirin After Coronary Stenting. The Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS) Circulation (Baltimore). 102, 624-629
WILCOX, R, 2000. European Heart Journal. 21(18), 1495-7
WONG, C.K., WHITE, H.D., WILCOX, R.G., CRIGER, D.A., CALIFF, R.M., TOPOL, E.J. and OHMAN, E.M., 2000. Does antiarrhythmic treatment alter outcome in AF complicating acute MI? The GUSTO III experience. Circulation (Baltimore). 102(18), 2779 Suppl.S
TOPOL, E. J., OHMAN, E. M., ARMSTRONG, P. W., WILCOX, R., SKENE, A. M., AYLWARD, P., SIMES, J., DALBY, A., BETRIU, A. and BODE, C., 2000. Survival Outcomes 1 Year After Reperfusion Therapy With Either Alteplase or Reteplase for Acute Myocardial Infarction: Results From the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial Circulation (Baltimore). VOL 102(PART 15), 1761-1765
WILCOX, R.G., BRAUNWALD, E., ANTMAN, E. and SKENE, A., 2000. European Heart Journal. 21, 2005-2013
HASDAI, D, HOLMES, D R, CRIGER, D A, TOPOL, E J, CALIFF, R M, WILCOX, R G, PAOLASSO, E, SIMOONS, M, DECKERS, J and HARRINGTON, R A, 2000. American Heart Journal. 139(3), 454-60
KLEIMAN, N S, LINCOFF, A M, FLAKER, G C, PIEPER, K S, WILCOX, R G, BERDAN, L G, LORENZ, T J, COKKINOS, D V, SIMOONS, M L, BOERSMA, E, TOPOL, E J, CALIFF, R M and HARRINGTON, R A, 2000. Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT Investigators. Circulation (New York, N.Y.). 101(7), 751-7
AKKERHUIS, K M, NEUHAUS, K L, WILCOX, R G, VAHANIAN, A, BOLAND, J L, HOFFMANN, J, BAARDMAN, T, NEHMIZ, G, ROTH, U, KLOOTWIJK, A P, DECKERS, J W, SIMOONS, M L and ,, 2000. European Heart Journal. 21(24), 2042-55
BOERSMA, E., PIEPER, K. S., STEYERBERG, E. W., WILCOX, R. G., CHANG, W.-C., LEE, K. L., AKKERHUIS, K. M., HARRINGTON, R. A., DECKERS, J. W. and ARMSTRONG, P. W., 2000. Predictors of Outcome in Patients With Acute Coronary Syndromes Without Persistent ST-Segment Elevation: Results From an International Trial of 9461 Patients Circulation (Baltimore). VOL 101(PART 22), 2557-2567
WONG, C K, WHITE, H D, WILCOX, R G, CRIGER, D A, CALIFF, R M, TOPOL, E J and OHMAN, E M, 2000. American Heart Journal. 140(6), 878-85
MOBINI, S., CHIANG, T.-J., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 2000. Psychopharmacology. VOL 152(PART 4), 390-397
MOBINI, S., CHIANG, T.-J., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 2000. Psychopharmacology. VOL 152(PART 1), 47-54
CHIANG, T.-J., AL-RUWAITEA, A. S. A., MOBINI, S., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 2000. Psychopharmacology. VOL 151(PART 4), 379-391
PHILLIPS, M. A., SZABADI, E. and BRADSHAW, C. M., 2000. Psychopharmacology. VOL 150(PART 1), 85-89
MOBINI, S., CHIANG, T.-J., AL-RUWAITEA, A. S., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 2000. Psychopharmacology. VOL 149(PART 3), 313-318
BROWN, N, MELVILLE, M, GRAY, D, YOUNG, T, SKENE, A M, WILCOX, R G and HAMPTON, J R, 1999. Heart. 81(6), 598-602
WILCOX, R.G., ANTMAN, E., BRAUNWALD, E., NEUHAUS, K. and SKENE, A.M., 1999. In-Time II: an equivalence trial of single bolus lanoteplase vs. accelerated alteplase in patients with acute myocardial infarction Heart. 81 Suppl.1, 38
OHMAN, E M, ARMSTRONG, P W, WHITE, H D, GRANGER, C B, WILCOX, R G, WEAVER, W D, GIBLER, W B, STEBBINS, A L, CIANCIOLO, C, CALIFF, R M and TOPOL, E J, 1999. American Journal of Cardiology. 84(11), 1281-6
STOREY, R.F., OLDROYD, K.G. and WILCOX, R.G., 1999. First clinical study of the novel platelet ADP receptor (P2T-) antagonist AR-C69931MX, assessing safety, tolerability and activity in patients with acute coronary syndromes Circulation (Baltimore). 100, I-710
HO, M.-Y., MOBINI, S., CHIANG, T.-J., BRADSHAW, C. M. and SZABADI, E., 1999. Psychopharmacology. VOL 146(NUMBER 4), 362-372
ABDULJAWAD, K A, LANGLEY, R W, BRADSHAW, C M and SZABADI, E, 1999. Effects of bromocriptine and haloperidol on prepulse inhibition: comparison of the acoustic startle eyeblink response and the N1/P2 auditory-evoked response in man. Journal of Psychopharmacology. 13(1), 3-9
PHILLIPS, M A, SZABADI, E and BRADSHAW, C M, 1999. The effects of the novel anxiolytic drug lesopitron, a full and selective 5-HT1A receptor agonist, on pupil diameter and oral temperature in man: comparison with buspirone. Journal of Psychopharmacology. 13(4), 391-7
AL-RUWAITEA, A S, CHIANG, T J, HO, M Y, BRADSHAW, C M and SZABADI, E, 1999. Psychopharmacology. 144(3), 264-71
ALEXANDER, J. H., HARRINGTON, R. A., TUTTLE, R. H., BERDAN, L. G., LINCOFF, A. M., DECKERS, J. W., SIMOONS, M. L., GUERCI, A., HOCHMAN, J. S. and WILCOX, R. G., 1999. American Journal of Cardiology. VOL 83(NUMBER 8), 1147-1151
WILCOX, R.G., 1999. Anglo Scandinavian Study of Early Thrombolysis: ASSET. In: Efficacy of Myocardial Infarction Therapy: an evaluation of Clinical Trials Evidence 15-24
HASDAI, D., HOLMES, D. R., TOPOL, E. J., BERGER, P. B., CRIGER, D. A., HOCHMAN, J. S., BATES, E. R., VAHANIAN, A., ARMSTRONG, P. W. and WILCOX, R., 1999. European Heart Journal. VOL 20(NUMBER 2), 128-135
WILCOX, R.G., 1999. Trial of early nifedipine in acute myocardial infarction: the TRENT Study. In: Efficacy of Myocardial Infarction Therapy: an evaluation of Clinical Trials Evidence 323-334
WILCOX, R., 1999. Heart. VOL 82(NUMBER 4), 405
BITSIOS, P., PHILPOTT, A., LANGLEY, R. W., BRADSHAW, C. M. and SZABADI, E., 1999. Journal of Psychopharmacology. VOL 13(NUMBER 3), 226-234
VIDALAKI, V.N., HO, M.-Y., BRADSHAW, C.M. and SZABADI, E., 1999. Neuropsychologia. VOL 37(NUMBER 9), 1061-1070
DAVIS, C, BRADSHAW, C M and SZABADI, E, 1999. British Journal of Clinical Psychology. 38 ( Pt 3), 305-14
AL-RUWAITEA, A. S. A., CHIANG, T.-J., AL-ZAHRANI, S. S. A., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 1999. Psychopharmacology. VOL 141(NUMBER 1), 22-29
CHIANG, T J, AL-RUWAITEA, A S, HO, M Y, BRADSHAW, C M and SZABADI, E, 1999. Psychopharmacology. 143(2), 166-73
ABDEBNAWLA, A. H., LANGLEY, R. W., SZABADI, E. and BRADSHAW, C. M., 1999. British Journal of Clinical Pharmacology. VOL 48(NUMBER 3), 345-354
BITSIOS, P., SZABADI, E. and BRADSHAW, C. M., 1999. Psychopharmacology. VOL 143(NUMBER 3), 286-292
STOREY, R F, WILCOX, R G and HEPTINSTALL, S, 1998. Differential effects of glycoprotein IIb/IIIa antagonists on platelet microaggregate and macroaggregate formation and effect of anticoagulant on antagonist potency. Implications for assay methodology and comparison of different antagonists. Circulation (Baltimore). 98(16), 1616-21
BITSIOS, P., SZABADI, E. and BRADSHAW, C. M., 1998. Journal of Psychopharmacology. VOL 12(NUMBER 2), 137-145
WOGAR, M. A., VAN DEN BROEK, M. D., BRADSHAW, C. M. and SZABADI, E., 1998. A new performance-curve method for the detection of simulated cognitive impairment British Journal of Clinical Psychology. VOL 37(NUMBER 3), 327-340
BITSIOS, P., LANGLEY, R. W., TAVERNOR, S., PYYKKOE, K., SCHEININ, M., SZABADI, E. and BRADSHAW, C. M., 1998. British Journal of Clinical Pharmacology. VOL 45(NUMBER 6), 551-558
BITSIOS, P., SZABADI, E. and BRADSHAW, C. M., 1998. Psychopharmacology. VOL 135(NUMBER 1), 93-98
ABDULJAWAD, K A, LANGLEY, R W, BRADSHAW, C M and SZABADI, E, 1998. Journal of Psychopharmacology. 12(3), 239-45
ABDELMAWLA, A. H., LANGLEY, R. W., SZABADI, E. and BRADSHAW, C. M., 1998. British Journal of Clinical Pharmacology. VOL 45(NUMBER 3), 271-276
SZABADI, E., BRADSHAW, C. M., BOSTON, P. F. and LANGLEY, R. W., 1998. Human Psychopharmacology: Clinical and Experimental. VOL 13 SUPP/1, S3-S12
GIBLER, W. B., WILCOX, R. G., BODE, C., CASTAIGNE, A. D., DELOOZ, H., ELICH, D., FOX, K. A. A., KEREIAKES, D. J., RUPPRECHT, H. and TOPOL, E. J., 1998. Annals of Emergency Medicine. VOL 32(NUMBER 6), 712-722
WILCOX, R.G., 1998. Horizons in Medicine
WILCOX, R.G., 1998. New England Journal of Medicine. 339, 436-43
BRIERLEY, C E, SZABADI, E, RIX, K J and BRADSHAW, C M, 1998. Journal of Affective Disorders. 15(1), 45-54
AL-ZAHRANI, S. S. A., AL-RUWAITEA, A. S. A., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 1998. Psychopharmacology. VOL 136(NUMBER 3), 235-242
CHIANG, T.-J., AL-RUWAITEA, A. S. A., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 1998. Behavioural Processes. VOL 44(ISSUE 2), 197-209
HO, M.-Y., AL-ZAHRANI, S. S. A., AL-RUWAITEA, A. S. A., BRADSHAW, C. M. and SZABADI, E., 1998. Journal of Psychopharmacology. VOL 12(NUMBER 1), 68-78
AL-ZAHRANI, S. S. A., AL-RUWAITEA, A. S. A., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 1997. Psychopharmacology. VOL 130(NUMBER 2), 166-173
AL-RUWAITEA, A. S. A., AL-ZAHRANI, S. S. A., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 1997. Psychopharmacology. VOL 134(NUMBER 2), 179-186
HO, M.-Y., WOGAR, M. A., BRADSHAW, C. M. and SZABADI, E., 1997. Choice between Delayed Reinforcers: Interaction between Delay and Deprivation Level Quarterly Journal of Experimental Psychology. Section B: Comparative and Physiological Psychology. VOL 50(NUMBER 3), 193-202
ABDELMAWLA, A. H., LANGLEY, R. W., SZABADI, E. and BRADSHAW, C. M., 1997. British Journal of Clinical Pharmacology. VOL 44(NUMBER 1), 61-68
ARYA, D. K., LANGLEY, R. W., SZABADI, E. and BRADSHAW, C. M., 1997. Naunyn-Schmiedeberg's Archives of Pharmacology. VOL 355(NUMBER 3), 376-383
WILCOX, R.G., 1997. New England Journal of Medicine. 337, 1118-23
WILCOX, R.G., 1997. New England Journal of Medicine. 337, 1124-30
BRADSHAW, C.M. and SZABADI, E., eds., 1997. Time and behaviour: psychological and neurobehavioural analyses Elsevier.
ABDULJAWAD, K A, LANGLEY, R W, BRADSHAW, C M and SZABADI, E, 1997. Journal of Psychopharmacology. 11(1), 29-34
AL-RUWAITEA,A.S., AL-ZAHRANI,S.S., HO,M., BRADSHAW,C.M. and SZABADI,E., 1997. 5-Hydroxytryptamine and interval timing.. In: BRADSHAW, C.M., ed., Time and behaviour: psychological and neurobehavioural analyses . Elsevier. 517-570
AL-ZAHRANI, S. S. A., HO, M.-Y., AL-RUWAITEA, A. S. A., BRADSHAW, C. M. and SZABADI, E., 1997. Psychopharmacology. VOL 129(NUMBER 1), 48-55
AL-ZAHRANI, S S, HO, M Y, VELAZQUEZ MARTINEZ, D N, LOPEZ CABRERA, M, BRADSHAW, C M and SZABADI, E, 1996. Psychopharmacology. 127(4), 346-52
ABDELMAWLA, A. H., LANGLEY, R. W., SZAHADI, E. and BRADSHAW, C. M., 1996. Naunyn-Schmiedeberg's Archives of Pharmacology. VOL 353(NUMBER 3), 324-327
ABDELMAWLA, A. H., LANGLEY, R. W., SZABADI, E. and BRADSHAW, C. M., 1996. Naunyn-Schmiedeberg's Archives of Pharmacology. VOL 354(NUMBER 1), 25-29
MORTLOCK, S A, LANGLEY, R W, BRADSHAW, C M and SZABADI, E, 1996. British Journal of Clinical Pharmacology. 42(2), 236-8
BITSIOS, P, LANGLEY, R W, SZABADI, E and BRADSHAW, C M, 1996. British Journal of Clinical Pharmacology. 41(4), 269-75
ABDELMAWLA, A. H., LANGLEY, R. W., SZABADI, E. and BRADSHAW, C. M., 1996. Journal of Pharmacological and Toxicological Methods. VOL 36(NUMBER 2), 77-80
HO, M.-Y., AL-ZAHRANI, S. S. A., VELAZQUEZ MARTINEZ, D. N., LOPEZ CABRERA, M., BRADSHAW, C. M. and SZABADI, E., 1996. Psychopharmacology. VOL 125(NUMBER 3), 274-284
SZABADI, E. and BRADSHAW, C. M., 1996. Autonomic pharmacology of 脿~2-adrenoceptors Journal of Psychopharmacology. VOL 10(NUMBER SUP//3), 6-18
AL-ZAHRANI, S S, HO, M Y, MARTINEZ, D N, CABRERA, M L, BRADSHAW, C M and SZABADI, E, 1996. Psychopharmacology. 123(1), 103-10
BITSIOS, P., SZABADI, E. and BRADSHAW, C. M., 1996. Journal of Psychopharmacology. VOL 10(NUMBER 4), 279-287
THEOFILOPOULOS, N, MCDADE, G, SZABADI, E and BRADSHAW, C M, 1995. British Journal of Clinical Pharmacology. 39(3), 251-5
HO,M.Y., AL-ZAHRANI,S.S., VELAZQUEZMARTINEZ,D.N., LOPEZCABRERA,M., BRADSHAW,C.M. and SZABADI,E., 1995. Psychopharmacology. 120(2), 213-219
SZABADI,E. and BRADSHAW,C.M., 1995. Affective disorders: Antidepressants. In: KING, D.J, ed., Seminars in Clinical Psychopharmacology 138-192
ABDELMAWLA, A. H., LANGLEY, R. W., SZABADI, E. and BRADSHAW, C. M., 1995. Comparison of the effects of desipramine on noradrenaline-and methoxamine-evoked venoconstriction in man British Journal of Clinical Pharmacology. VOL 40(NUMBER 5), 445
HO,M.Y., VELAZQUEZMARTINEZ,D.N., LOPEZCABRERA,M., AL-ZAHRANI,S.S., BRADSHAW,C.M. and SZABADI,E., 1995. Psychopharmacology. 118(3), 332-337
VAN DEN BROEK, M D and BRADSHAW, C M, 1994. Detection of acquired deficits in general intelligence using the National Adult Reading Test and Raven's Standard Progressive Matrices. British Journal of Clinical Psychology. 33 ( Pt 4), 509-15
GRAHAM, S, HO, M Y, BRADSHAW, C M and SZABADI, E, 1994. Psychopharmacology. 116(3), 373-8
MORRISSEY, G., HO, M.-Y., WOGAR, M. A. and BRADSHAW, C. M., 1994. Psychopharmacology. VOL 114(NUMBER 3), 463
VANDENBROEK,M.D. and BRADSHAW,C.M., 1993. Personality and Individual Differences. 14(4), 531-534
WOGAR, M A, BRADSHAW, C M and SZABADI, E, 1993. Psychopharmacology. 112(1), 86-92
MORRISSEY, G., WOGAR, M. A., BRADSHAW, C. M. and SZABADI, E., 1993. Psychopharmacology. VOL 112(NUMBER 1), 80
VANDENBROEK,M.D., BRADSHAW,C.M. and SZABADI,E., 1993. Utility of the Wisconsin Card Sorting Test in neuropsychological assessment British Journal of Clinical Psychology. 32(3), 333-343
BRADSHAW, C. M. and SZABADI, E., 1993. Herrnstein's Equation: Data From 110 Rats Psychological Reports. VOL 73(NUMBER 3//PT2), 1355
WOGAR, M. A., BRADSHAW, C. M. and SZABADI, E., 1993. Psychopharmacology. VOL 111(NUMBER 2), 239
BOURNE, M., SZABADI, E. and BRADSHAW, C. M., 1993. European Journal of Clinical Pharmacology. VOL 44(NUMBER 1), 57
LEUNG, N K, BRADSHAW, C M and SZABADI, E, 1992. Effect of high ambient temperature on the kinetics of the pupillary light reflex in healthy volunteers. British Journal of Clinical Pharmacology. 33(4), 458-60
WOGAR,M.A., BRADSHAW,C.M. and SZABADI,E., 1992. Choice between delayed reinforcers in an adjusting-delay schedule: the effects of absolute reinforcer size and deprivation level Quarterly Journal of Experimental Psychology. Section B: Comparative and Physiological Psychology. 45B(1), 1-13
VANDENBROEK,M.D., BRADSHAW,C.M. and SZABADI,E., 1992. The relationship between Personality and Individual Differences. 13(3), 355-360
WOGAR, M A, BRADSHAW, C M and SZABADI, E, 1992. Psychopharmacology. 107(2-3), 373-8
BRADSHAW, C M and SZABADI, E, 1992. Choice between delayed reinforcers in a discrete-trials schedule: the effect of deprivation level. Quarterly Journal of Experimental Psychology. Section B: Comparative and Physiological Psychology. 44(1), 1-6
VANDENBROEK,M.D., BRADSHAW,C.M. and SZABADI,E., 1992. Personality and Individual Differences. 13(2), 169-174
FLETT,S.R., SZABADI,E. and BRADSHAW,C.M., 1992. European Journal of Clinical Pharmacology. 42, 529-533
SZABADI, E. and BRADSHAW, C.M., eds., 1991. Adrenoceptors: Structure, Mechanisms, Function Birkhauser.
SHAH,K., BRADSHAW,C.M. and SZABADI,E., 1991. Relative and absolute reinforcement frequency as determinants of choice in concurrent variable interval schedules Quarterly Journal of Experimental Psychology. Section B: Comparative and Physiological Psychology. 43B(1), 25-38
WOGAR,M.A., BRADSHAW,C.M. and SZABADI,E., 1991. Psychopharmacology. 105(1), 119-124
VANDENBROEK,M.D. and BRADSHAW,C.M., 1990. Intellectual decline and the assessment of premorbid intelligence. In: BEECH,J. R. and HARDING L, eds., Assessment of the Elderly NFER-Nelson, London.
SHAH,K., BRADSHAW,C.M. and SZABADI,E., 1990. Psychopharmacology. 100(4), 548-554
LONGMORE,J., BERRY,J.L., SZABADI,E. and BRADSHAW,C.M., 1990. European Journal of Clinical Pharmacology. 39, 305-309
BAKES,A., BRADSHAW,C.M. and SZABADI,E., 1990. Attenuation of the pupillary light reflex in anxious patients British Journal of Clinical Pharmacology. 30, 377-381
THEOFILOPOULOS, N., GRAY, C.M., SZABADI, E. and BRADSHAW, C.M., 1989. Human Psychopharmacology: Clinical and Experimental. 4, 129-134
BANJAR, W M, BRADSHAW, C M and SZABADI, E, 1989. Seasonal variation in responsiveness of human eccrine sweat glands to phenylephrine. British Journal of Clinical Pharmacology. 27(2), 276-8
BRADSHAW,C.M. and SZABADI,E., 1989. Central neurotransmitter systems and the control of operant behaviour by. In: LIEBMAN, J.M. and COOPER, S.J, eds., The Neuropharmacological Basis of Reward, Clarendon Press.
SHAH,K., BRADSHAW,C.M. and SZABADI,E., 1989. Performance of humans in concurrent variable ratio schedules of monetary reinforcement. Psychological Reports. 65(2), 515-520
THEOFILOPOULOS, N, LONGMORE, J, KERR, F A, SZABADI, E and BRADSHAW, C M, 1988. British Journal of Clinical Pharmacology. 26(6), 697-702
LONGMORE, J, BANJAR, W, BRADSHAW, C M and SZABADI, E, 1988. European Journal of Clinical Pharmacology. 34(1), 97-9
SZABADI,E. and BRADSHAW,C.M., 1988. Biological markers for anxiety states. In: GRANVILLE-GROSSMAN,K.L. and WING,P., eds., Recent Advances in Clinical Psychiatry 6. Churchill Livingstone. 69-99
BRADSHAW, C.M., 1988. Biological markers for anxiety states. In: Recent Advances in Clinical Psychiatry 6. 69-99
BRADSHAW,C.M. and SZABADI,E., 1988. Quantitative analysis of human operant behavior. In: DAVEY,G. and CULLEN,C., eds., Human Operant Conditioning and Behavior Modification John Wiley & Sons. 225-259
MORLEY, M J, SHAH, K, BRADSHAW, C M and SZABADI, E, 1988. Psychopharmacology. 96(4), 551-6
VANDENBROEK,M.D., BRADSHAW,C.M. and SZABADI,E., 1987. Behaviour of Personality and Individual Differences. 8(2), 233-239
SZABADI,E. and BRADSHAW,C.M., 1987. Alpha 1 adrenergic receptors in the central nervous system. In: RUFFOLO,R.R., ed., The Alpha 1 Adrenergic Receptors Humana Press. 405-453
VAN DEN BROEK, M D, BRADSHAW, C M and SZABADI, E, 1987. Performance of normal adults on the Matching Familiar Figures Test. British Journal of Clinical Psychology. 26 ( Pt 1), 71-2
BRADSHAW, C.M., SHERIDAN, R.D. and SZABADI, E., 1987. Neuropharmacology. 26, 1195-1200
BANJAR, W, LONGMORE, J, BRADSHAW, C M and SZABADI, E, 1987. European Journal of Clinical Pharmacology. 31(6), 661-5
LONGMORE, J, BANJAR, W, SZABADI, E and BRADSHAW, C M, 1987. British Journal of Clinical Pharmacology. 23(2), 245-6
MORLEY,M.J., BRADSHAW,C.M. and SZABADI,E., 1987. Psychopharmacology. 91(2), 239-243
MORLEY, M J, BRADSHAW, C M and SZABADI, E, 1987. Psychopharmacology. 93(4), 520-5
MORLEY,M.J., BRADSHAW,C.M. and SZABADI,E., 1987. Psychopharmacology. 92(2), 247-253
SZABADI,E. and BRADSHAW,C.M., 1986. Antidepressant drugs and the autonomic nervous system. In: DEAKIN,J.F.W., ed., The Biology of Depression Gaskell. 190-220
LONGMORE, J, JANI, B, BRADSHAW, C M and SZABADI, E, 1986. British Journal of Clinical Pharmacology. 21(2), 131-5